NASDAQ: ADMA
Adma Biologics Inc Stock Ownership - Who owns Adma Biologics?

Insider buying vs selling

Have Adma Biologics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kaitlin M. KestenbergmessinaCOO and SVP Compliance2025-01-305,000$10.80
$54.00kBuy
Kaitlin M. KestenbergmessinaCOO and SVP Compliance2025-01-303,355$16.10
$54.02kSell
Adam S. GrossmanPresident and CEO2024-12-3114,343$17.15
$245.98kSell
Kaitlin M. KestenbergmessinaCOO and SVP Compliance2024-12-311,854$17.15
$31.80kSell
Steve ElmsDirector2024-11-279,000$10.80
$97.20kBuy
Adam S. GrossmanPresident and CEO2024-11-2248,967$21.10
$1.03MSell
Brad L. TadeCFO and Treasurer2024-11-2215,000$21.15
$317.25kSell
Kaitlin M. KestenbergmessinaCOO and SVP Compliance2024-09-302,647$19.99
$52.91kSell
Adam S. GrossmanPresident and CEO2024-09-3021,752$19.99
$434.82kSell
Lawrence P. GuiheenDirector2024-09-099,000$10.80
$97.20kBuy

1 of 5

ADMA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADMA insiders and whales buy or sell their stock.

ADMA Shareholders

What type of owners hold Adma Biologics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc16.14%38,149,937$606.58MInstitution
Vanguard Group Inc7.70%18,198,796$289.36MInstitution
State Street Corp6.29%14,870,747$236.44MInstitution
Perceptive Advisors LLC5.61%13,262,375$210.87MInsider
Divestiture Trust Biotest5.45%12,886,740$204.90MInsider
Invesco Ltd4.78%11,296,255$179.61MInstitution
Ag Biotest4.28%10,109,534$160.74MInsider
Aisling Capital II LP2.60%6,136,998$97.58MInsider
Geode Capital Management LLC2.30%5,432,384$86.37MInstitution
Dimensional Fund Advisors LP1.97%4,668,320$74.23MInstitution

1 of 3

ADMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADMA76.49%23.51%Net SellingNet Selling
RNA86.72%13.28%Net SellingNet Selling
RARE79.21%17.10%Net SellingNet Selling
ACLX44.86%55.14%Net SellingNet Selling
AKRO68.30%31.70%Net BuyingNet Buying

Adma Biologics Stock Ownership FAQ

Who owns Adma Biologics?

Adma Biologics (NASDAQ: ADMA) is owned by 76.91% institutional shareholders, 23.63% Adma Biologics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Adma Biologics shareholder, owning 13.26M shares representing 5.61% of the company. Perceptive Advisors LLC's Adma Biologics shares are currently valued at $210.87M.

If you're new to stock investing, here's how to buy Adma Biologics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.